Related Experiment Videos
Illegal or medical amphetamine – what has the patient taken?
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Nitazene-related deaths in Norway 2021-2024.
Forensic science international·2026
Impact of Sex, Age, Body Composition and Kidney Function on the Relationship Between Self-Reported Alcohol Consumption and Phosphatidylethanol-Data From the HUNT Study.
Basic & clinical pharmacology & toxicology·2025
Effect of Bariatric Surgery on the Pharmacokinetics of Codeine, Oxycodone and Tramadol-A Case Series.
Basic & clinical pharmacology & toxicology·2025
Etonitazepyne in counterfeit oxycodone tablets-a fatal case report.
Journal of analytical toxicology·2025
Pharmacokinetic Variability of Amlodipine Serum Concentration and Effect on Blood Pressure in Patients Treated for Hypertension.
Pharmacology research & perspectives·2025
Adnexal torsion due to teratoma in a young adolescent.
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Acute dizziness - resource use and diagnosis with targeted clinical examination.
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Data quality in the Norwegian National Quality Registry for Pain Management.
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Mirogabalin, C12H19NO2, and mirogabalin besylate, C12H20NO2+·C6H5O3S.
Acta crystallographica. Section C, Structural chemistry·2026
What is in the bottle? An analysis of the ingredients in menopause supplements.
Climacteric : the journal of the International Menopause Society·2026
Non-Prescribed Gabapentinoid Use: Demographic and Behavioural Risk Profiles in a Large International Sample.
Drug and alcohol review·2026
Effects of intestinal permeation enhancers on solubilization and epithelial transport of the proteolysis targeting chimera (PROTAC) ARV-471 in rats.
Journal of controlled release : official journal of the Controlled Release Society·2026
Special Populations in Pivotal Clinical Trials: Eligibility and Supporting Evidence for Exclusion in EMA-Authorised Medicines.
Clinical pharmacology and therapeutics·2026